MBBEONE@EC2601A(17914.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
MBBEONE@EC2601A
17914.HK
News
View More

BEONE MEDICINES (6160.HK): Range-bound fluctuations, cautious and repeated capital movements, the pharmaceutical sector's new regulations lead to increasingly complex speculation

On February 3rd, BeiGene experienced significant fluctuations throughout the day, opening high and then pulling back. Although funds were somewhat active in the short term, supporting a slight rebound, the overall trend showed weakness. Currently, the pharmaceutical sector is relatively mild, with some long-term funds testing the waters as the market rebounds. The main operators displayed clear hesitation and repetition, with the day's rhythm primarily characterized by strong fluctuations. Recently, the market has focused on news such as "new contracts flowing out of the CXO business," which has activated short-term funds related to pharmaceuticals. However, despite increased trading volume, the main funds still primarily engaged in range trading, leading to intensified overall bullish-bearish divergence and a strong wait-and-see atmosphere. The MACD daily signal has shown some phase repair, but the resistance area above the stock price and long-term pressure remain heavy, with no clear signs of sustained upward movement from the main operators. On the news front, there are currently no major disturbances in the pharmaceutical sector, and thematic rotations and active funds have revealed structural opportunities. The intraday performance showed a high opening and pullback, with multiple tests of the 20-day line, where right-side funds dominated the intraday game. However, the volume cooperation was limited, restricting the rebound space, and the signals from large orders were scattered. Overall, a new round of regulatory details for the pharmaceutical industry is about to be released, becoming a key focus for the market and significantly impacting the sector's trend. The risk exposure cannot be ignored; if negative news arises or the main operators significantly reduce their holdings, the pressure will intensify. It is recommended to continue monitoring policy dynamics and changes in the pharmaceutical sector's hotspots, dynamically managing positions to cope with uncertainties

Technical Forecast·
HK
06160
-0.19%
SZ
159316
+3.20%
SZ
159892
+2.68%
Technical Forecast·
HK
06160
-0.19%
SZ
159316
+3.20%
SZ
159892
+2.68%

In "Major Banks," CICC lists potential "blue-chip" companies for the Hang Seng Index's semi-annual adjustment (table)

CICC released a report predicting potential companies for inclusion in the Hang Seng Index's semi-annual adjustment, including Zijin Mining International, Beigene, YUM China, etc., along with the possible weight and capital inflow situation. At the same time, companies such as Standard Chartered and Swire Properties may be included in the Hang Seng Index as replacements due to the delisting of Hang Seng Bank

AASTOCKS·
US
BGNE
0.00%
SH
688235
+3.28%
HK
06160
-0.19%
AASTOCKS·
US
BGNE
0.00%
SH
688235
+3.28%
HK
06160
-0.19%

Beigene's "BeYueDa" completes its first sale in Beijing

China National Pharmaceutical Group announced that as the preferred distributor for BeiGene's new product "BaYueDa" in Beijing, it successfully completed the first order delivery for BeiGene yesterday (14th). The medication arrived at China National Pharmaceutical Group's logistics in the afternoon of the same day, and with the cooperation and coordination of relevant departments such as the procurement center, Beijing direct sales center, and China National Pharmaceutical Group logistics, it was delivered to the designated DTP pharmacy within 3 hours after arrival

AASTOCKS·
SH
688235
+3.28%
US
BGNE
0.00%
HK
06160
-0.19%
AASTOCKS·
SH
688235
+3.28%
US
BGNE
0.00%
HK
06160
-0.19%

Hong Kong Exchanges and Clearing (HKEX) launches new stock options category

Hong Kong Exchanges and Clearing (HKEX) announced that it will launch six new categories of stock options on January 19, 2026, to expand the stock options market and provide more choices for investors. Last year, the average daily trading volume of the derivatives market at HKEX reached a new high, and the average daily trading volume of stock options also increased significantly. The newly launched options include stocks from companies such as Zijin Mining, Wuxi AppTec, and Beigene, with contract trading units and expiration months already announced

港交所·
SH
603259
+2.68%
HK
02359
+3.79%
US
HKXCY
+1.42%
港交所·
SH
603259
+2.68%
HK
02359
+3.79%
US
HKXCY
+1.42%
Posts
View More

$Beigene(ONC.US)$Zai Lab(ZLAB.US)Trump administration plans to impose strict controls on Chinese pharmaceuticals

mp.weixin.qq.com/s/gihUP-...

The annual portfolio return for 2024 is around 8%, far below expectations. This is mainly due to significant negative contributions from $PDD(PDD.US) and $Li Auto(LI.US).

Tonight, I will open a new U.S...

  • 0
© 2026 Longbridge｜Disclaimer